Newsfeed : Study Shows that Longer Treatment Course Could Halve Mother-to-Child HIV Transmission

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Newsfeed » July 2008

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


July 10, 2008

Study Shows that Longer Treatment Course Could Halve Mother-to-Child HIV Transmission

According to a new study, giving extended antiretroviral regimens to infants of HIV-positive mothers significantly reduces the chance of transmitting the virus through breast feeding, The Baltimore Sun reports (, 7/10).

Researchers at the Johns Hopkins Bloomberg School of Public Health separated 3,016 breast-feeding infants in Malawi into three groups: One group of babies got a single dose of nevirapine; in another, they received the drug for 14 weeks; the third group received a combination of nevirapine and zidovudine, another HIV medication, for 14 weeks. In the latter two groups HIV infections were reduced by half, with the infants showing no harmful side effects from the longer treatments.

“The study has a big sample size, so the data is really strong,” pediatrician and study coauthor Mary Glenn Fowler told the Sun. According to the article, health officials in Malawi and elsewhere are planning on rolling out the treatment in the near future.

Search: mother-to-child, zidovudine, nevirapine

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.